- General information enquiries
- Call 00 800 6 7 8 9 10 11
- E-mail your questions
European Commission
Public Health
Accessibility tools
Service tools
Language selector
- Current languageen
Navigation path
- European Commission
- Public health
- Reference documents
- Register
- Orphan products
- Propranolol hydrochloride
Pharmaceuticals - Community Register
Community register of orphan medicinal products | GRANTED |
Product information |
Propranolol hydrochloride
| EU orphan designation number: | EU/3/17/1841
|
| Active ingredient: | Propranolol hydrochloride |
| Indication: | Treatment of von Hippel-Lindau disease |
| Sponsor: | Consejo Superior de Investigaciones Cientificas (CSIC)
C/ Serrano 142, E-28006 Madrid, España |
Public summary of scientific opinion
European Commission procedures |
| Close date procedure | Procedure type | EMEA number | Decision | summary publ | decision docs | annex |
| 01/03/2017 | Orphan designation | EMA/OD/256/16 | (2017)1507 of 27/02/2017 |
CONTACT
EU links
Directorate General Health & Consumers